BioEridan Presented Underwater Biotechnology Research
The firm has showcased its sub-sea cultivation methods as it seeks to develop new longevity-focused ingredients.
Updated on Sept. 21, 2026 in Biotech
Live Poll
Do you support prioritizing investment in biotechnology research focused on human longevity and healthy ageing?
BioEridan premiered a documentary detailing its research into telomeres and bioactive ingredients cultivated in underwater farms. The company conducted screenings in Belgrade and at the University of Cambridge this September to highlight its work in controlled-environment biotechnology.
Why it matters
By moving research facilities 13 metres underwater, BioEridan is attempting to find novel pathways for longevity science. The initiative aims to position Serbia as a recognized contributor to the global biotechnology market.
BioEridan utilizes controlled hydroponic systems placed 13 metres beneath the sea surface. These specialized facilities are designed to maintain precise environmental conditions for cultivating plants used in telomere and longevity research.
The players
BioEridan
A biotechnology firm developing controlled underwater hydroponic systems for longevity research.
TS Ventures Fund
A corporate venture capital firm established in 2021 with €25 million in capital to support regional innovation.
The details
The Aquafarms are submerged pressurized modules that utilize controlled hydroponic systems—a method of growing plants in nutrient-rich water solutions without soil. This approach allows researchers to manipulate environmental variables to isolate specific plant expressions that may influence telomeres, which are the protective caps at the end of DNA strands. The firm intends to use these harvests to create bioactive ingredients—naturally occurring compounds with biological activity—for future longevity products.
Timeline
2021: TS Ventures Fund was established.
September 15, 2026: Documentary premiered in Belgrade.
September 16, 2026: Documentary screening at Christ's College, University of Cambridge.
The Tech Race
BioEridan is attempting to carve out a niche in the competitive longevity supplement market by utilizing unconventional undersea environments. The project aligns with the goals set out at the UK-Serbia Health, Digital Transformation & Innovation roundtable to expand the influence of regional biotech.
The development of longevity-focused bioactive ingredients remains in the research stage, with no consumer products currently available to the public. Future availability will depend on the successful translation of these sub-sea cultivation trials into scalable manufacturing processes.
The takeaway
BioEridan is testing whether extreme, controlled environments can yield unique bioactive compounds for longevity science. Observers should track the firm's progress in clinical trials or ingredient stability testing to see if the underwater research model produces commercially viable results.
Further reading
For broader trends in longevity research and specialized cultivation, explore our Biotech archive.
More information
Read more about the recent project developments in the View the full press release.
Live Poll
Do you support prioritizing investment in biotechnology research focused on human longevity and healthy ageing?
